1. What Is the ATAC Seq Market?
The ATAC Seq Market covers assay for transposase-accessible chromatin sequencing platforms, single-cell ATAC-seq instruments, multiome ATAC and RNA combined assay systems, and bioinformatics tools. These technologies profile open chromatin regions and active gene regulatory elements genome-wide. Applications include drug target identification from regulatory element activity, cancer driver enhancer mapping, stem cell differentiation regulatory network analysis, and epigenomic biomarker discovery. Market dynamics reflect growing regulatory genomics drug target research, single-cell ATAC adoption, multiome multi-omics integration, and chromatin accessibility clinical biomarker development. Falling sequencing costs are expanding ATAC-seq accessibility beyond specialized epigenomics laboratories.
2. ATAC Seq Market Size & Forecast
3. Emerging Technologies
- CUT&TAG chromatin profiling achieving ATAC-like data at lower sequencing depth are advancing. Growing adoption is driven by cost efficiency for large-cohort histone and transcription factor mapping.
- Clinical blood-based cell-free chromatin accessibility profiling for cancer liquid biopsy are advancing. Growing interest is driven by non-invasive tumor regulatory landscape monitoring from blood samples.
- ATAC-seq chromatin accessibility spatial mapping combined with spatial gene expression are advancing. Growing use is driven by tumor regulatory landscape mapping with preserved tissue architecture context.
- Deep learning chromatin accessibility models predicting regulatory element activity from sequence are advancing. Growing adoption is driven by drug target regulatory element prediction without experimental ATAC-seq.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Epigenomics Market.
4. Key Market Opportunity
The primary opportunity in the ATAC Seq Market is pharmaceutical regulatory genomics drug target discovery. Single-cell multiome ATAC+RNA platform creates premium reagent market from scATAC adoption. Clinical chromatin accessibility liquid biopsy creates an emerging diagnostic market segment. Asia Pacific ATAC-seq adoption in China and Japan creates geographic market opportunity.
5. Top Companies in the ATAC Seq Market
The following organisations hold leading positions in the ATAC Seq Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- 10x Genomics (scATAC, Multiome)
- Active Motif (ATAC-seq reagents, CUT&TAG)
- Diagenode (chromatin shearing, CUT&TAG)
- Zymo Research (ATAC-seq kits)
- New England Biolabs (library prep)
- Illumina (sequencing library kits)
- Arima Genomics (Hi-C chromatin)
- Dovetail Genomics
- Phase Genomics
- EpiCypher (CUT&TAG antibodies)
6. Market Segmentation
The ATAC Seq Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Type | Bulk ATAC-seq Single-Cell ATAC-seq Multiome ATAC+RNA CUT&TAG Chromatin Profiling |
| By Application | Drug Target Regulatory Genomics Cancer Driver Enhancer Mapping Stem Cell Research |
| By End User | Academic Epigenomics Labs Pharmaceutical Drug Discovery Biotech CROs |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the ATAC Seq Market trajectory over the forecast period:
Regulatory Genomics ATAC-seq Is Identifying Non-Coding Enhancer Drug Targets Missed by Coding Genomics.Open chromatin ATAC-seq data reveals active enhancers driving cancer driver gene overexpression. These regulatory elements are emerging as novel drug targets beyond protein-coding gene products. Transcription factor binding at accessible chromatin identified by ATAC-seq guides epigenetic drug discovery. Pharmaceutical epigenomics programs use ATAC-seq to identify cell-type-specific regulatory vulnerabilities.
Single-Cell ATAC-seq Is Revealing Chromatin Accessibility Heterogeneity in Complex Tissue Environments.10x Genomics' Chromium single-cell ATAC kit profiles open chromatin in thousands of individual cells. This resolves cell-type-specific regulatory program activity within heterogeneous tissue samples. Tumor single-cell ATAC profiles identify cancer stem cell regulatory states driving drug resistance. scATAC-seq is advancing as a complementary single-cell genomics tool alongside scRNA-seq profiling.
Multiome ATAC and RNA Simultaneously Profiling Chromatin and Expression Advances Multi-Omics Research.10x Genomics' Multiome ATAC+GEX kit captures both chromatin accessibility and RNA in single cells. This dual measurement enables direct gene regulatory network inference from single-cell data. Multiome data is used to link cell-type-specific enhancers to their regulated gene expression targets. The Multiome platform is driving convergence of transcriptomics and epigenomics at single-cell resolution.
For related market intelligence, see the Single Cell Rna Sequencing Market.
8. Segmental Analysis
By type, the Bulk ATAC-seq segment dominated the ATAC Seq Market in 2025 as the most established method. It provides the broadest chromatin accessibility profiling for population and tissue-level epigenomics studies. The Multiome ATAC+RNA segment is fastest-growing, driven by single-cell multi-omics integration research demand.
9. Regional Analysis
Regional demand patterns across the ATAC Seq Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the ATAC Seq Market in 2025 with a market share of 45.0%. The region hosts 10x Genomics and Active Motif and the leading ATAC-seq platform and reagent developers. NIH-funded epigenomics programs including ENCODE and Roadmap Epigenomics drive institutional ATAC-seq demand. Moreover, US pharmaceutical regulatory genomics programs lead commercial ATAC-seq adoption for target discovery. In addition, North American academic centers drive multiome ATAC+RNA method development. Platform leadership and program funding sustain North American ATAC Seq Market dominance.
Highest CAGR Region
Asia Pacific is projected to register the highest CAGR of 31.50% in the ATAC Seq Market through 2034. China's epigenomics research investment and pharmaceutical regulatory genomics programs are expanding rapidly. Japan's academic chromatin biology programs and pharmaceutical epigenomic drug target programs create demand. Moreover, South Korea's precision oncology epigenomics programs create additional ATAC-seq platform adoption. Research growth and pharmaceutical investment position Asia Pacific for sustained ATAC Seq Market outperformance.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The ATAC Seq Market was valued at USD 400.00 Mn in 2025 and is projected to reach USD 2,484.80 Mn by 2034, growing at a CAGR of 22.50% over the 2026–2034 forecast period.
The ATAC Seq Market is projected to grow at a CAGR of 22.50% from 2026 to 2034.
North America dominated the ATAC Seq Market in 2025 with a market share of 45.0%.
The leading companies in the ATAC Seq Market include 10x Genomics (scATAC, Multiome), Active Motif (ATAC-seq reagents, CUT&TAG), Diagenode (chromatin shearing, CUT&TAG), Zymo Research (ATAC-seq kits), New England Biolabs (library prep), Illumina (sequencing library kits), Arima Genomics (Hi-C chromatin), Dovetail Genomics, Phase Genomics, EpiCypher (CUT&TAG antibodies).
Regulatory genomics atac-seq is identifying non-coding enhancer drug targets missed by coding genomics.
By type, the Bulk ATAC-seq segment dominated the ATAC Seq Market in 2025 as the most established method.
How to Order
Choose Your Package
Condensed edition of this study for students, researchers and academic institutions.
- Condensed edition of the full study
- For students, researchers & academic institutions
- Valid student ID or institutional email required
- Educational, non-commercial use only
The competitive landscape, including key market participants, company size, market positioning, and comparative competitive standing.
- 15 in-depth company profiles
- Company overview
- Product and brand portfolio mapped per company
- Revenue for the last 3 FYs with key financial metrics
- Segmental revenue and regional revenue breakdown
- Market presence, key geographies & end-use industries
- Recent developments
- Key capabilities, differentiators & strategic positioning
- SWOT Analysis
- 15-company market share analysis
- 2025 market share by company
- Company revenue in USD
- Competitive quadrant positioning
- Product portfolio comparison
The complete forecast model, including every study table, is provided in clean, formula-ready Excel format across 3 segmentation axes. Select the geographic coverage required for your analysis.
- One country, broken out across 3 segmentation axes
- 2025 base year, 2026–2034 forecast, CAGR per line
- Excel workbook
- Region totals plus every country inside that region
- All axes, all years, CAGR per line
- Cross-country comparison sheet included
- Excel workbook
- Every forecast table in the study
- Global, regional and country views in one workbook
- Segment share and CAGR pivots included
- Excel workbook
The full syndicated study. Every chapter, every region, every country, plus the complete Excel model, methodology and appendix.
- Executive summary, market scope & segmental snapshot
- Market dynamics: drivers, restraints, opportunities, challenges
- Quantitative analysis across 3 segmentation axes
- Regional analysis
- Competitive landscape, market share & company revenue mapping
- Includes the full Global Excel Data Pack
- Complete research methodology, assumptions & appendix
TAM/SAM/SOM sizing, M&A target screening, patent & IP analysis, supply-chain resilience mapping, ESG roadmaps and other bespoke strategic work.
- TAM / SAM / SOM sizing
- M&A target screening
- Patent & IP analysis
- Supply-chain resilience mapping
- ESG roadmaps & other bespoke strategic work
Not sure which package fits? Tell us the decision you are making and an analyst will recommend the smallest package that answers it. Talk to an analyst.
Ordering Process
Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.